ALK Status Testing in Non–Small Cell Lung Carcinoma

Slides:



Advertisements
Similar presentations
Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Advertisements

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases Syed A. Ahmed, Karen Snow-Bailey, W. Edward Highsmith,
CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.
Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection James Goldmeyer,
Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Kenji Nakano, Elizabeth Watney,
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Quantification of Parvovirus B19 DNA Using COBAS AmpliPrep Automated Sample Preparation and LightCycler Real-Time PCR Stefan Schorling, Gunnar Schalasta,
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens Matthew D. Wilkerson, Jason M. Schallheim, D. Neil Hayes, Patrick.
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma  Zhen.
Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
Carol Beadling, Tanaya L. Neff, Michael C
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario  Ricardo.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors  Neal I. Lindeman, Philip T. Cagle, Mary.
Molecular Genetics of Pediatric Soft Tissue Tumors
ALK FISH and IHC: You Cannot Have One without the Other
Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma  Zhen.
Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost- Impact Analysis  Linda M. Sabatini, Charles Mathews, Devon Ptak, Shivang Doshi,
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Increased Sensitivity of the Roche COBAS AMPLICOR HCV Test, Version 2
Maxim B. Freidin, Neesa Bhudia, Eric Lim, Andrew G
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang,
A Lean Laboratory The Journal of Molecular Diagnostics
Patrick R. Murray  The Journal of Molecular Diagnostics 
Chronic Myeloid Leukemia
William L. Gerald, M.D., Ph.D, 1954–2008
Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer  Maruja E. Lira, Tae Min Kim, Donghui Huang, Shibing Deng,
Kyong-Ah Yoon, Sohee Park, Sang Hee Lee, Jin Hee Kim, Jin Soo Lee 
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
Pedram Gerami, Susan S. Jewell, Pedram Pouryazdanparast, Jeffery D
The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations  Michaël Boudewijns, Jacques.
Development of an NPM1/MLF1 D-FISH Probe Set for the Detection of t(3;5)(q25;q35) Identified in Patients with Acute Myeloid Leukemia  Umut Aypar, Ryan.
Raymond R. Tubbs, James Pettay, Pat Roche, Mark H
Diagnosis of BK Viral Nephropathy in the Renal Allograft Biopsy
BRAF Mutation Testing in Solid Tumors
Mutational Analysis of BRAF Inhibitor–Associated Squamoproliferative Lesions  Britt Clynick, Tania Tabone, Kathryn Fuller, Wendy Erber, Katie Meehan, Michael.
The Molecular Pathology of Primary Immunodeficiencies
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non–Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue  Shuguang Huang, Nicholas.
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
The Pitfalls of Companion Diagnostics
Retrospective Comparison of Nucleic Acid Sequence–Based Amplification, Real-Time PCR, and Galactomannan Test for Diagnosis of Invasive Aspergillosis 
Molecular Monitoring of Chronic Myeloid Leukemia
Ayalew Tefferi, Pierre Noel, Curtis A. Hanson 
Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry  Yan.
High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer  Yan Feng, MD, Eugen C. Minca, MD,
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
Novel Method for PIK3CA Mutation Analysis
Diagnosis of BK Viral Nephropathy in the Renal Allograft Biopsy
Use of Pyrosequencing of 16S rRNA Fragments to Differentiate between Bacteria Responsible for Neonatal Sepsis  Jeanne A. Jordan, Allyson R. Butchko, Mary.
Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent 
Karen Snow-Bailey, Ph.D., 1961–2006
Pathologic correlates of heparin-free donation after cardiac death in lung transplantation  Chase R. Brown, BS, Alexis E. Shafii, MD, Carol F. Farver,
Jie Hu, Malini Sathanoori, Sally J. Kochmar, Urvashi Surti 
Journal of Investigative Dermatology
Varying Mutational Alterations in Multiple Primary Melanomas
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Clinical Experience with the Cervista HPV HR Assay
Angiotensin I-Converting Enzyme
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and.
ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material  Eugen C. Minca, MD, PhD, Christopher P. Lanigan,
Presentation transcript:

ALK Status Testing in Non–Small Cell Lung Carcinoma Eugen C. Minca, Bryce P. Portier, Zhen Wang, Christopher Lanigan, Carol F. Farver, Yan Feng, Patrick C. Ma, Valeria A. Arrossi, Nathan A. Pennell, Raymond R. Tubbs  The Journal of Molecular Diagnostics  Volume 15, Issue 3, Pages 341-346 (May 2013) DOI: 10.1016/j.jmoldx.2013.01.004 Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 IHC for ALK expression. Representative images of NSCLC (A) positive for ALK expression by D5F3-IHC (B) and for ALK rearrangements by FFPE-FISH (C) and ThinPrep-FISH (D). Original magnification: ×100 (A and B); ×1000 (C and D). The Journal of Molecular Diagnostics 2013 15, 341-346DOI: (10.1016/j.jmoldx.2013.01.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions